Abbott, NEOGEN Corporation and OraSure Technologies, Inc. are Dominating in the North America Saliva Test Devices Market in 2020

North America Saliva Test Devices Market is expected to grow with the CAGR of 6.4% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below:

Access Full Report @ https://www.databridgemarketresearch.com/reports/north-america-saliva-test-devices-market

North America saliva test devices market is a highly consolidated market which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.    

The major players dealing in North America saliva test devices market are introducing strong range of products provider along with launching new products and adopting strategic initiative such as acquisition and agreement into the market. This has helped the companies to maximize the sales with enhanced product portfolio. For instance, in January 2021, OraSure Technologies, Inc. subsidiary named DNA Genotek announced that its product named OMNIgene·ORAL (OM-505) saliva collection kit has received Health Canada approval for sale in Canadian market for its use in molecular diagnostic tests for the detection of SARS-CoV-2. This Health Canada authorization received by the company has increased its sales and revenue in future.

Abbott is the dominating player in North America saliva test devices market. The other key players existing in the saliva test devices market includes OraSure Technologies, Inc., Premier Biotech, Inc., Confirm Biosciences, GC America Inc., Thermo Fisher Scientific Inc., DNA Genotek Inc. (a subsidiary of OraSure Technologies, Inc.), BNTX Inc., Vitagene, Alfa Scientific Designs, Inc., NEOGEN Corporation, Oranoxis Inc., Oasis Diagnostics Corporation, Salimetrics, LLC, Immunalysis Corporation, Avellino, Securetec among others.

 North America Saliva Test Devices Market Abbott:

Abbott is headquartered in Illinois, U.S. and was founded in 1888. The company focuses on manufacturing products in diagnostics, medical devices, nutrition and branded generic pharmaceuticals that help people to live healthier lives and full of unlimited possibilities. The company deals in multiple business segments such as established pharmaceutical products, nutritional products, diagnostic products and medical devices among which diagnostic products is the market focused segment. The company is providing products under categories such as consumers and healthcare professionals out of which consumers are the market focused category. The company is engaged in continuous development of saliva test devices.   

For instance,

  • In December 2019, Abbott announced that its product named SoToxa Mobile Test System has been recognized as one of the top ten innovations in the Health category for the year 2019. This recognition received by the company’s product has increased its sales and demand in the market leading to increased revenue in future.

The company has wide presence across Asia-Pacific, Europe, Middle East and Africa, North America and South America. The company has various subsidiaries such as Abbott Cardiovascular Systems Inc. (U.S.), Abbott Nutrition Manufacturing Inc. (U.S.), Abbott Laboratories Pacific Ltd. (U.S.), Abbott Resources Inc. (U.S.) and PDD II, LLC (U.S.) among others.

NEOGEN Corporation:

NEOGEN Corporation is headquartered in Michigan, U.S. and was founded in 1982. The company is engaged in offering wide range of solutions and services for the food processing, animal protein and agriculture industries along with life science and toxicology sector. The company has two business segments namely food safety and animal safety in which animal safety is the market focused segment. The company is providing products under categories such as animal safety, food safety, genomics, life sciences and toxicology among which toxicology is the market focused category. The company is engaged in continuous development of saliva test devices.   

For instance,

  • In January 2020, NEOGEN Corporation announced that it has acquired the Productos Quimicos Magiar, a distributor of the company’s food safety diagnostics leading to increased sales and revenue in future.

The company has wide presence across Europe, North America, South America, Asia-Pacific and Middle East and Africa. The company also has various subsidiary companies such as Neogen Bio-Scientific Technology Co (Shanghai) (China), Neogen Food and Animal Security (India), Neogen Canada, Neogen do Brasil (Brazil) and Neogen Chile SpA (Chile) among others.

OraSure Technologies, Inc.:

OraSure Technologies, Inc. is headquartered in Pennsylvania, U.S. The company is engaged in the development, manufacturing and distribution of rapid diagnostic tests, sample collection and stabilization devices and molecular services solutions designed to detect critical medical conditions. The company has two business segments namely diagnostics business and molecular solutions business in which diagnostics business is the market focused segment. The company is engaged in providing products under categories such as diagnostics & testing sampling tools out of which diagnostics & testing is the market focused category. The company has initiated many strategic initiatives to expand its market.

For instance,

  • In January 2021, OraSure Technologies, Inc. subsidiary named DNA Genotek announced that its product named OMNIgene·ORAL (OM-505) saliva collection kit has been issued Emergency Use Authorization (EUA) granted Ambry Genetics for use in the Ambry COVID-19 RT-PCR saliva test. This EUA grant received by the company has increased its sales and revenue in future.

The company has wide presence across Europe, North America, South America, Middle East and Africa and Asia-Pacific. The company has various subsidiary companies such as DNA Genotek, Inc. (Canada), Novosanis (Belgium), Diversigen (Houston) (U.S.) and Diversigen (Minneapolis) (U.S.) among others.